kras mutation and glutathion glutathione pancreatic cancer How survives ferroptosis? Pancreatic ductal adenocarcinoma (PDAC) tumors harboring mutations exhibit Selective killing of cancer cells
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Frontiers Targeting KRAS: The Elephant in the Room of Epithelial Cancers Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



